Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cue Biopharma, Inc. (CUE)  
$1.37 0.04 (3.19%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,500,000
Market Cap: 40.27(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.41 - $4.91
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cue Biopharma is a biopharmaceutical company engineering a class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body. Co. is focusing on drug product candidates for treating cancer in its CUE-100 series, which exploits rationally engineered interleukin 2, in context of the key Immuno- Selective Targeting and Alteration of T Cells framework for selective activation of targeted tumor-specific T cells. Co. is seeking third party support through partnerships and collaborations, or alternative funding structures, to further develop its programs outside of oncology, including its CUE-200, CUE-300 and CUE-400 series.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 7,000 240,000
Total Buy Value $0 $0 $19,620 $836,320
Total People Bought 0 0 2 4
Total Buy Transactions 0 0 2 5
Total Shares Sold 0 0 0 9,325
Total Sell Value $0 $0 $0 $30,586
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 112
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Suri Anish PRESIDENT AND CSO   •       –      –    2023-08-25 4 B $2.76 $11,040 D/D 4,000 135,638 2.74 -4%     
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-14 4 B $2.86 $8,580 D/D 3,000 134,578 2.81 -11%     
   Verheyen Patrick Director   –       •      –    2023-04-11 3 IO $0.00 $0 D/D 0 8,174 -4%     
   Kiener Peter A Director   –       •      –    2023-03-23 4 S $3.28 $30,586 D/D (9,325) 357 -11%     
   Kiener Peter A Director   –       •      –    2023-03-23 4 OE $2.86 $27,691 D/D 9,682 9,682     -
   Levisetti Matteo Chief Medical OfficerOfficer   •       –      –    2023-01-17 3 IO $0.00 $0 D/D 0 9,230 18%     
   Millar Kerri-Ann CHIEF FINANCIAL OFFICER   •       –      –    2022-08-22 4 D $3.05 $8,625 D/D (2,828) 14,311     -
   Millar Kerri-Ann CHIEF FINANCIAL OFFICER   •       –      –    2022-08-21 4 OE $0.00 $0 D/D 6,667 17,139     -
   Gray Cameron Director   –       •      –    2022-06-14 4 D $3.20 $164,998 D/D (51,562) 687,049     -
   Gray Cameron Director   –       •      –    2022-06-14 4 OE $2.70 $165,000 D/D 61,111 738,611     -
   Morich Frank Director   –       •      –    2022-05-27 4 B $3.75 $105,000 D/D 28,000 28,000 2.39 -21%     
   Fletcher Aaron G.l. Director   –       •      –    2022-05-24 4 B $3.34 $183,700 I/I 55,000 940,000 2.1 -7%     
   Fletcher Aaron G.l. Director   –       •      –    2022-05-23 4 B $3.52 $528,000 I/I 150,000 885,000 2.1 -33%     
   Suri Anish PRESIDENT AND CSO   •       –      –    2022-03-31 4 D $4.88 $34,492 D/D (7,068) 103,638     -
   Suri Anish PRESIDENT AND CSO   •       –      –    2022-03-31 4 OE $0.00 $0 D/D 16,668 110,706     -
   Fletcher Aaron G.l. Director   –       •      –    2022-03-31 4 B $4.76 $3,498,600 I/I 735,000 735,000 2.1 -34%     
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2022-03-31 4 GD $0.00 $0 D/D 10,000 131,578     -
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2022-03-31 4 D $4.88 $156,755 D/D (32,122) 141,578     -
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2022-03-31 4 OE $0.00 $0 D/D 75,000 173,700     -
   Kiener Peter A Director   –       •      –    2021-11-16 4 AS $18.02 $24,525 D/D (1,361) 0 -73%     
   Kiener Peter A Director   –       •      –    2021-11-16 4 OE $2.86 $3,892 D/D 1,361 1,361     -
   Kiener Peter A Director   –       •      –    2021-11-15 4 AS $17.92 $337,165 D/D (18,815) 0 -72%     
   Kiener Peter A Director   –       •      –    2021-11-15 4 OE $2.86 $53,811 D/D 18,815 18,815     -
   Suri Anish President and CSO   •       –      –    2021-11-15 4 AS $18.05 $144,400 D/D (8,000) 94,038 -72%     
   Suri Anish President and CSO   •       –      –    2021-11-15 4 OE $8.26 $66,080 D/D 8,000 102,038     -
  112 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us